Page 79 - AN-2-2

Advanced Neurology Role of immunosuppressants in autism

31. Hutsler JJ, Zhang H, 2010, Increased dendritic spine https://doi.org/10.1371/journal.pone.0035885
densities on cortical projection neurons in autism spectrum 42. Buckmaster PS, Ingram EA, Wen X, 2009, Inhibition of
disorders. Brain Res, 1309: 83–94.
the mammalian target of rapamycin signaling pathway
https://doi.org/10.1016/j.brainres.2009.09.120 suppresses dentate granule cell axon sprouting in a rodent
model of temporal lobe epilepsy. J Neurosci, 29: 8259–8269.
32. Winden KD, Ebrahimi-Fakhari D, Sahin M, 2018, Abnormal
mTOR activation in autism. Annu Rev Neurosci, 41: 1–23. https://doi.org/10.1523/jneurosci.4179-08.2009
https://doi.org/10.1146/annurev-neuro-080317-061747 43. Onore C, Yang H, Van de Water J, et al., 2017, Dynamic Akt/
mTOR signaling in children with autism spectrum disorder.
33. Zhang B, Wong M, 2012, Pentylenetetrazole‐induced Front Pediatr, 5: 43.
seizures cause acute, but not chronic, mTOR pathway
activation in rat. Epilepsia, 53: 506–511. https://doi.org/10.3389/fped.2017.00043
https://doi.org/10.1111/j.1528-1167.2011.03384.x 44. Neniskyte U, Gross CT, 2017, Errant gardeners: Glial-cell-
dependent synaptic pruning and neurodevelopmental
34. Gatto CL, Broadie K, 2010, Genetic controls balancing excitatory disorders. Nat Rev Neurosci, 18: 658–670.
and inhibitory synaptogenesis in neurodevelopmental
disorder models. Front Synaptic Neurosci, 2: 4. https://doi.org/10.1038/nrn.2017.110
https://doi.org/10.3389/fnsyn.2010.00004 45. Wong M, 2019, The role of glia in epilepsy, intellectual
disability, and other neurodevelopmental disorders in
35. Won H, Mah W, Kim E, 2013, Autism spectrum disorder tuberous sclerosis complex. J Neurodev Disord, 11: 30.
causes, mechanisms, and treatments: Focus on neuronal
synapses. Front Mol Neurosci, 6: 19. https://doi.org/10.1186/s11689-019-9289-6
https://doi.org/10.3389/fnmol.2013.00019 46. Yui K, Sato A, Imataka G, 2015, Mitochondrial dysfunction and
its relationship with mTOR signaling and oxidative damage in
36. Lin TV, Hsieh L, Kimura T, et al., 2016, Normalizing autism spectrum disorders. Mini Rev Med Chem, 15: 373–389.
translation through 4E-BP prevents mTOR-driven cortical
mislamination and ameliorates aberrant neuron integration. https://doi.org/10.2174/1389557515666150324122930
Proc Natl Acad Sci U S A, 113: 11330–11335. 47. Leite JA, Orellana AM, Kinoshita PF, et al., 2017,
https://doi.org/10.1073/pnas.1605740113 Neuroinflammation and neurotransmission mechanisms
involved in neuropsychiatric disorders. In: Mechanisms of
37. Tylee DS, Espinoza AJ, Hess JL, et al., 2017, RNA sequencing Neuroinflammation. London: IntechOpen.
of transformed lymphoblastoid cells from siblings discordant
for autism spectrum disorders reveals transcriptomic and https://doi.org/10.5772/intechopen.69343
functional alterations: Evidence for sex-specific effects. 48. Andrews MG, Subramanian L, Kriegstein AR, 2020, mTOR
Autism Res, 10: 439–455. signaling regulates the morphology and migration of outer
https://doi.org/10.1002/aur.1679 radial glia in developing human cortex. Elife, 9: e58737.
38. Kassai H, Sugaya Y, Noda S, et al., 2014, Selective activation https://doi.org/10.7554/elife.58737
of mTORC1 signaling recapitulates microcephaly, tuberous 49. Da Silva Vaccaro T, Sorrentino JM, Salvador S, et al.,
sclerosis, and neurodegenerative diseases. Cell Rep, 7: 1626–1639. 2018, Alterations in the microRNA of the blood of autism
https://doi.org/10.1016/j.celrep.2014.04.048 spectrum disorder patients: Effects on epigenetic regulation
and potential biomarkers. Behav Sci (Basel), 8: 75.
39. Magri L, Cambiaghi M, Cominelli M, et al., 2011, Sustained
activation of mTOR pathway in embryonic neural stem https://doi.org/10.3390/bs8080075
cells leads to development of tuberous sclerosis complex- 50. Gevezova M, Sarafian V, Anderson G, et al., 2020, Inflammation
associated lesions. Cell Stem Cell, 9: 447–462. and mitochondrial dysfunction in autism spectrum disorder.
https://doi.org/10.1016/j.stem.2011.09.008 CNS Neurol Disord Drug Targets, 19: 320–333.
40. Jernigan CS, Goswami DB, Austin MC, et al., 2011, The mTOR https://doi.org/10.2174/1871527319666200628015039
signaling pathway in the prefrontal cortex is compromised 51. Meltzer A, Van de Water J, 2017, The role of the immune system
in major depressive disorder. Prog Neuropsychopharmacol in autism spectrum disorder. Neuropsychopharmacology,
Biol Psychiatry, 35: 1774–1779. 42: 284–298.
https://doi.org/10.1016/j.pnpbp.2011.05.010 https://doi.org/10.1038/npp.2016.158
41. Talos DM, Sun H, Zhou X, et al., 2012, The interaction 52. Gilmore JH, Jarskog LF, Vadlamudi S, 2005, Maternal poly I:
between early life epilepsy and autistic-like behavioral C exposure during pregnancy regulates TNF alpha, BDNF,
consequences: A role for the mammalian target of rapamycin and NGF expression in neonatal brain and the maternal-
(mTOR) pathway. PLoS One, 7: e35885. fetal unit of the rat. J Neuroimmunol, 159: 106–112.

Volume 2 Issue 2 (2023) 19 https://doi.org/10.36922/an.391